Skip to main content

Table 2 Mean absorbed dose per administered activity [Gy/GBq] in normal tissues and bone metastases estimated by the three dosimetry methods

From: Comparison of different methods for post-therapeutic dosimetry in [177Lu]Lu-PSMA-617 radioligand therapy

Mean dose [Gy/GBq]

2D

Hybrid

3D

Parotid gland

0.75 ± 0.34

0.81 ± 0.34

0.81 ± 0.34

Submandibular gland

0.71 ± 0.36

0.73 ± 0.39

0.72 ± 0.39

Kidneys

0.49 ± 0.31

0.52 ± 0.27

0.54 ± 0.28

Liver

0.09 ± 0.04

0.10 ± 0.05

0.10 ± 0.05

Bone metastases

1.42 ± 0.99

1.55 ± 1.28

1.68 ± 1.32